18 October 2024 in Science Advances
Stem cell therapies for Parkinson’s disease are at an exciting time of development, and several clinical trials have recently been initiated. Human pluripotent stem cells are differentiated into transplantable dopamine (DA) progenitors which are proliferative at the time of grafting and undergo terminal differentiation and maturation in vivo. While the progenitors are homogeneous at the time of transplantation, they give rise to heterogeneous grafts composed not only of therapeutic DA neurons but also of other mature cell types. The mechanisms for graft diversification are unclear. We used single-nucleus RNA-seq and ATAC-seq to profile DA progenitors before transplantation combined with molecular barcode-based tracing to determine origin and shared lineages of the mature cell types in the grafts. Our data demonstrate that astrocytes, vascular leptomeningeal cells, and DA neurons are the main component of the DAergic grafts, originating from a common progenitor that is tripotent at the time of transplantation.
20 May 2022 in Blood Advances
The fetal-to-adult switch in hematopoietic stem cell (HSC) behavior is characterized by alterations in lineage output and entry into deep quiescence. Here we identify the emergence of megakaryocyte (Mk)-biased HSCs as an event coinciding with this developmental switch. Single-cell chromatin accessibility analysis reveals a ubiquitous acquisition of Mk lineage priming signatures in HSCs during the fetal-to-adult transition. These molecular changes functionally coincide with increased amplitude of early Mk differentiation events after acute inflammatory insult. Importantly, we identify LIN28B, known for its role in promoting fetal-like self-renewal, as an insulator against the establishment of an Mk-biased HSC pool. LIN28B protein is developmentally silenced in the third week of life, and its prolonged expression delays emergency platelet output in young adult mice. We propose that developmental regulation of Mk priming may represent a switch for HSCs to toggle between prioritizing self-renewal in the fetus and increased host protection in postnatal life.
8 September 2026 in bioRxiv
The early-life B cell repertoire is disproportionately enriched for self-reactive specificities in mice and humans, raising the question of how this ontogenic permissiveness is achieved. The predominant B cell central tolerance mechanism edits away self-reactivity by secondary rearrangements of the immunoglobulin light chain (IgL) following strong B cell receptor (BCR) engagement during the immature B cell stage. Here, we demonstrate a layer of developmental regulation, imposed by the early-life restricted RNA-binding protein LIN28B, that suppresses the incidence and capacity for IgL secondary rearrangements during ontogeny. Genetic dissection demonstrated that the underlying mechanisms operate independent of BCR specificity or pre-BCR requirement, dissociating the receptor editing fate from strict BCR instruction. We identified an adult-specific receptor editing-biased pre-B cell state marked by CD25 expression and metabolic quiescence. LIN28B subverted this state, shifting the balance from secondary rearrangements to positive selection and bone marrow egress. Together, our results demonstrate that the central tolerance threshold is an ontogenically tuned parameter, providing insights into the self-reactivity bias that characterizes the early-life B cell repertoire. One Sentence Summary: The developmentally restricted RNA-binding protein LIN28B limits the extent of Immunoglobulin light chain receptor editing to shift the balance from stringent self-tolerance towards accelerated B cell output early in life.
13 November 2022 in bioRxiv
The LIN28B RNA binding protein exhibits a ontogenically restricted expression pattern and is a key molecular regulator of fetal and neonatal B lymphopoiesis. It enhances the positive selection of CD5+ immature B cells early in life through amplifying the CD19/PI3K/c-MYC pathway and is sufficient to reinitiate self-reactive B-1a cell output when ectopically expressed in the adult. In this study, interactome analysis in primary B cell precursors showed direct binding by LIN28B to numerous ribosomal protein transcripts, consistent with a regulatory role in cellular protein synthesis. Induction of LIN28B expression in the adult setting is sufficient to promote enhanced protein synthesis during the small Pre-B and immature B cell stages, but not during the Pro-B cell stage. This stage dependent effect was dictated by IL-7 mediated signaling, which masked the impact of LIN28B through an overpowering stimulation on the c-MYC / protein synthesis axis in Pro-B cells. Importantly, elevated protein synthesis was a distinguishing feature between neonatal and adult B cell development that was critically supported by endogenous Lin28b expression early in life. Finally, we used a ribosomal hypomorphic mouse model to demonstrate that subdued protein synthesis is specifically detrimental for neonatal B lymphopoiesis and the output of B-1a cells, without affecting B cell development in the adult. Taken together, we identify elevated protein synthesis as a defining requirement for early-life B cell development that critically depends on Lin28b . Our findings offer new mechanistic insights into the layered formation of the complex adult B cell repertoire.